The Amazing Biomedical Data Platforms in New York
Stop Waiting Months for Data: Access 20M+ Records on a Biomedical Data Platform New York
Biomedical data platform New York initiatives are changing how researchers access and analyze patient data. The city hosts some of the nation’s most powerful health data infrastructures—from Healthix‘s network covering over 20 million individuals to Mount Sinai’s AI-ready multi-modal platform and the INSIGHT Clinical Research Network’s repository of 160 million patient encounters.
Key New York Biomedical Data Platforms:
- Healthix: Nation’s largest public health information exchange with 20M+ patient records
- Mount Sinai AIR·MS: Multi-modal platform linking clinical, genomic, and imaging data
- INSIGHT Clinical Research Network: 160M+ encounters and 365M+ diagnoses from NYC institutions
- New York Genome Center: Advanced genomics and bioinformatics for precision medicine
These platforms address a critical challenge: data silos. Patient information sits trapped across hospitals, labs, and research centers. Traditional access takes weeks or months. Researchers need programming skills. Compliance requirements create bottlenecks.
New York’s platforms are changing this. They enable real-time access to de-identified data. They support no-code workflows for non-technical researchers. They maintain HIPAA and GDPR compliance while accelerating discovery from months to minutes.
I’m Maria Chatzou Dunford, CEO and Co-founder of Lifebit, a pioneering genomics and biomedical data platform that powers federated data analysis globally. With over 15 years in computational biology, AI, and health-tech entrepreneurship, I’ve helped public sector institutions and pharmaceutical organizations leverage secure, compliant biomedical data platforms to accelerate drug discovery and precision medicine.
Access 20 Million+ Patient Records Instantly with Lifebit’s Federated Platform
When we talk about the scale of a biomedical data platform New York researchers can use, we have to start with the sheer volume of available information. The New York ecosystem is home to Healthix, the largest public health information exchange (HIE) in the United States. It doesn’t just hold data; it moves it across thousands of organizations, from massive hospital systems to tiny community clinics.
At Lifebit, we believe that data shouldn’t have to move to be useful. Our federated AI platform allows us to bring the analysis to the data, rather than the other way around. This is crucial when dealing with the records of over 20 million individuals. By using a federated approach, we ensure that sensitive patient information stays secure within its original environment while still providing researchers with the population health insights they need to save lives.
Real-Time Insights for Faster Research Breakthroughs
In New York medicine, “yesterday’s data” is often not good enough. Modern platforms now prioritize unified clinical data that includes 16 core health measures mandated by the New York State Department of Health (NYSDOH). These include everything from vital signs and immunizations to complex lab results and care plans.
Our platform connects data partners to provide instant analytics. Imagine being able to query millions of records for real-time medication fills or emergency department visits without waiting for a manual data pull. This speed is what allows New York institutions to respond to public health crises or identify emerging disease patterns in days rather than months.
Powering Community Health and Equity
New York’s data ecosystem isn’t just for big pharma; it’s a lifeline for community-based organizations (CBOs). Recent pilot projects in the city have focused on empowering housing-focused CBOs with real-time data access. By linking social determinants of health—like housing stability—with clinical outcomes, these initiatives are driving true health equity. We see this as the future of the biomedical data platform New York space: a world where social services and medical care are unified by data to support the city’s most vulnerable populations.
End Data Silos: Use AI-Ready Infrastructure to Connect New York Research
The biggest “pain point” we hear from scientists is that data is siloed. A patient might have genomic testing at the New York Genome Center, clinical visits at Mount Sinai, and imaging done at a private clinic. Traditionally, these data types never meet.
Lifebit’s high-performance, cloud-based platform is designed to break these walls down. We provide a biomedical data access guide to help researchers steer these complex waters, ensuring that multi-modal data—genomics, EMR, and imaging—can be integrated into a single, cohesive research environment.
Instantly Search and Analyze Clinical Notes, Genomics, and More
One of the most exciting developments in New York is the rise of “AI-ready” data. Platforms like Mount Sinai’s AIR·MS are leading the charge by linking patient data from different clinical departments. This includes:
- Full-text search of unstructured clinical notes (progress notes, nursing notes, etc.).
- Pathology metadata and high-resolution imaging.
- Somatic genomic testing results in both structured and raw formats.
By making this data “AI-ready,” we enable researchers to build machine learning models that can predict patient outcomes with startling accuracy. You can learn more about our AI-ready platform and how it handles these diverse data modalities.
No-Code Workflows: Analyze Data Without IT Bottlenecks
Let’s be honest: not every brilliant biologist is a brilliant coder. For too long, research has been bottlenecked by the need for specialized bioinformaticians to run every single analysis. New York is now home to tools like the Playbook Workflow Builder, which uses a “LEGO-piece” approach to data science.
Researchers can now use LLM-powered chatbots and drag-and-drop interfaces to:
- Design custom analytical pipelines.
- Generate automated documentation and step-by-step methods.
- Ensure reproducibility by exporting workflows in standardized formats.
We are proud to support this shift toward no-code biomedical analysis, allowing scientists to focus on the “science” rather than the “syntax.”
Cut Discovery Time: Analyze 160M+ Patient Encounters on One Platform
To understand a disease, you need to see the whole story, not just a snapshot. This is where longitudinal data becomes vital. In New York, the INSIGHT Clinical Research Network provides a staggering repository of over 160 million patient encounters and 365 million diagnoses. This isn’t just a list; it’s a historical record of how health evolves over time across one of the most diverse populations on Earth.
Our longitudinal data solutions are built to handle this complexity. By tracking patient journeys across years, researchers can identify the long-term effects of treatments and the early warning signs of chronic conditions.
High-Impact Datasets for Clinical and Population Health Research
The datasets available through New York’s platforms are some of the most comprehensive in the world. They cover:
- Electronic Health Records (EHR) from major medical schools and research centers.
- COVID-19 Outcomes: Detailed data on hospital admissions and severe outcomes, particularly in older adults.
- Patient-Reported Outcomes: Moving beyond what the doctor sees to how the patient actually feels.
Accessing this data often requires a rigorous application process, but we help support clinical research by providing the secure infrastructure needed to meet IRB and fee-based access requirements.
Real-World Evidence for Chronic Disease and Outcomes
New York researchers are currently using these platforms to tackle the city’s biggest health challenges. Recent studies have utilized the biomedical data platform New York infrastructure to track the decline in high-risk glucose control agents for diabetes and to investigate pediatric urinary tract infections. By using real-world evidence (RWE), we can move faster than traditional clinical trials, building cohorts in minutes to see what is actually happening in the “real world.”
From Variant to Target: Unify Genomics and Clinical Data in One Platform
New York is a global hub for genomic innovation. The New York Genome Center (NYGC) acts as a collaborative engine, bringing together interdisciplinary teams of scientists and programmers to conduct research in human genomics. Their work spans cancer, Mendelian diseases, and complex disorders.
Lifebit’s multi-omic data platform is designed to complement these efforts. By integrating genomics with other “omics” (like proteomics and transcriptomics) and real-world clinical data, we provide a 360-degree view of human biology.
AI-Powered Discovery: From Genomics to Real-World Evidence
The acquisition of the New York Stem Cell Foundation (NYSCF) by The Jackson Laboratory (JAX) is a prime example of where the industry is heading. This partnership integrates:
- Mouse genetics and preclinical modeling.
- Stem cell science and high-throughput automation.
- AI-powered data analysis to reveal disease mechanisms earlier.
This unified discovery engine allows researchers to test therapies in a “digital twin” environment before they ever reach a patient, significantly reducing the risk and cost of drug development.
Seamless Bioinformatics and Data Processing
Bioinformatics at the scale of a city like New York requires serious horsepower. The Computational Biology group at NYGC, for instance, focuses on speeding up genomic data analysis pipelines and translating those improvements into better healthcare data. Our platform supports these interdisciplinary groups by providing automated pipelines that can handle the massive data loads generated by Whole Genome Sequencing (WGS) and Whole Exome Sequencing (WES).
Protect Patient Privacy with Synthetic and Privacy-Preserving Data Tools
Not every research project requires—or should have—access to identifiable patient data. Privacy is our North Star. That’s why the biomedical data platform New York ecosystem is increasingly turning to synthetic data and privacy-preserving analytics.
Our guide to AI platforms explains how these technologies work. By using tools like the OMOP Common Data Model, we can standardize data from different sources, making it “speak the same language” while keeping the actual patient identities locked away.
Build and Test ML Models with Synthetic Claims Data
One of the most useful tools for researchers today is the CMS DE-SynPUF (Synthetic Public Use Files). This dataset offers a synthetic version of Medicare claims data.
- No IRB Required: Because the data is synthetic, you can get onboarded and start building ML models immediately.
- Statistical Integrity: It maintains the statistical properties of the original data without disclosing any real patient information.
- ML-Ready: It is an exemplary tool for testing healthcare algorithms and applications.
We facilitate OMOP integration for these synthetic sets, allowing you to align them with other clinical datasets for robust, privacy-first research.
Global Scale, Local Compliance: Federated AI for R&D
While we are focused on New York, the research world is global. Accessing diverse datasets is essential for studying rare diseases or ensuring that drug trials are representative of all populations.
However, global data brings global compliance headaches (GDPR, HIPAA, etc.). Lifebit solves this through federated AI. We empower you to find pharmaceutical insights across borders without ever moving the data, ensuring you stay compliant with local laws while conducting world-class R&D.
FAQs: How Lifebit Secures Your Biomedical Data Platform New York
How does Lifebit provide secure access to 20M+ patient records?
We use a federated AI architecture. Instead of pulling 20 million records into a single, vulnerable database, our platform connects to the data where it lives (at hospitals or HIEs like Healthix). We provide the “Trusted Research Environment” where researchers can run their code against the data securely. This ensures real-time updates and strict privacy controls are always maintained.
Can researchers use no-code tools for biomedical data analysis?
Absolutely. We recognize that the future of medicine is interdisciplinary. Our platform supports modular, drag-and-drop workflow builders and LLM-powered chatbots (similar to the Playbook Workflow Builder) that allow scientists to ask questions in natural language and receive biologically grounded answers without writing a single line of Python or R.
How does Lifebit support IRB and compliance requirements?
We provide a secure Trusted Research Environment (TRE) that includes built-in audit trails, de-identification tools, and regulatory-compliant data handling. Our platform is designed to align with the standards of major New York institutions, providing “IRB-ready” workflows that simplify the administrative burden on researchers while maintaining the highest levels of data security.
Conclusion: Start Your Research in Minutes, Not Months
The biomedical data platform New York landscape is a powerhouse of innovation, offering unprecedented access to clinical, genomic, and real-world data. From the 20 million records at Healthix to the advanced AI workflows at Mount Sinai, the tools available to New York researchers are truly world-class.
At Lifebit, we are proud to be part of this ecosystem, providing the federated AI and secure infrastructure that makes this data actionable. Whether you are looking for a Trusted Research Environment to analyze multi-omic data or a Trusted Data Lakehouse to unify your clinical records, we are here to help you accelerate your discovery.